High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels. Urick ME, Yu EJ, Bell DW. Cancer 2021 Apr 19. doi: 10.1002/cncr.33567.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Urick ME, Yu EJ, Bell DW. High-risk endometrial cancer proteomic profiling reveals that FBXW7 mutation alters L1CAM and TGM2 protein levels. Cancer 2021 Apr 19. doi: 10.1002/cncr.33567.
PMID: 33872388